Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bertelsen

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancerJ S Nielsen, E Jakobsen, B Hølund, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 1993
Prognostic factors and adjuvant treatment in early epithelial ovarian cancerK. Bertelsen, B. Hølund, J.E. Andersen, et al.
Gynecologic Oncology|March 30, 2001
Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinomaP Sørensen, M Høyer, A Jakobsen, et al.
Gynecologic Oncology|May 1, 1990
Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapyP Pfeiffer, S Cold, K Bertelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Use of tumour markers in monitoring the course of ovarian cancerG J Rustin, A E Nelstrop, S M Bentzen, et al.
Gynecologic Oncology|November 1, 1996
A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancerH Havsteen, K Bertelsen, C C Gadeberg, et al.
Scandinavian Journal of Gastroenterology|January 1, 1992
Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood testO Kronborg, C Fenger, J Worm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapyJ T Thigpen, K Bertelsen, E A Eisenhauer, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Weekly oral idarubicin in advanced prostatic cancer. A phase II studyE L Madsen, L Bastholt, K Bertelsen, et al.
Ugeskrift for Laeger|July 11, 1977
[Value of clinical follow-up examinations in patients treated for breast cancer, cervix-uteri cancer and malignant skin melanoma]S Ogaard, J Seidelin, H Brincker, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancerJ S Nielsen, E Jakobsen, B Hølund, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 1, 1993
Prognostic factors and adjuvant treatment in early epithelial ovarian cancerK. Bertelsen, B. Hølund, J.E. Andersen, et al.
Gynecologic Oncology|March 30, 2001
Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinomaP Sørensen, M Høyer, A Jakobsen, et al.
Gynecologic Oncology|May 1, 1990
Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapyP Pfeiffer, S Cold, K Bertelsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 1999
Use of tumour markers in monitoring the course of ovarian cancerG J Rustin, A E Nelstrop, S M Bentzen, et al.
Gynecologic Oncology|November 1, 1996
A phase 2 study with epirubicin as second-line treatment of patients with advanced epithelial ovarian cancerH Havsteen, K Bertelsen, C C Gadeberg, et al.
Scandinavian Journal of Gastroenterology|January 1, 1992
Causes of death during the first 5 years of a randomized trial of mass screening for colorectal cancer with fecal occult blood testO Kronborg, C Fenger, J Worm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapyJ T Thigpen, K Bertelsen, E A Eisenhauer, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Weekly oral idarubicin in advanced prostatic cancer. A phase II studyE L Madsen, L Bastholt, K Bertelsen, et al.
Ugeskrift for Laeger|July 11, 1977
[Value of clinical follow-up examinations in patients treated for breast cancer, cervix-uteri cancer and malignant skin melanoma]S Ogaard, J Seidelin, H Brincker, et al.
Pageof 8